Activation of /3-adrenergic receptors with isoproterenol fails to stimulate prostaglandin synthesis in the isolated rabbit heart perfused with Ca 2+ -free Krebs-Henseleit buffer. This lack of response could be due to reduced isoproterenol-stimulated liberation of arachidonic acid, reduced cyclooxygenase activity during Ca 2+ -free perfusion, or both. To test these hypotheses, we have examined the effect of isoproterenol and exogenous arachidonic acid on prostaglandin output in hearts perfused with Ca 2+ -containing and nominally Ca 2+ -free Krebs-Henseleit buffer. In hearts prelabelled with [ 3 H]arachidonic acid and perfused with nominally Ca 2+ -free buffer, the release of radioactivity following isoproterenol was about 90% less than when Ca 2+ was included in the perfusion buffer. When exogenous arachidonic acid was administered to hearts perfused with Ca 2+ -depleted buffer, the output of both 6-keto-prostaglandin F la and prostaglandin E 2 was about threefold greater than when Ca 2+ was present in the perfusion medium. In the absence of Ca 2+ , the dose response curve for arachidonic acid-induced 6-keto-prostaglandin F la synthesis underwent a parallel shift to the left, with no change in maximal synthesis levels, and a tenfold reduction in the ED 50 of arachidonic acid. The cyclooxygenase activities of cell-free homogenates prepared from hearts perfused with and without Ca 2+ were not different from each other and were both insensitive to added Ca 2+ . Reduction of the Na + concentration of the perfusion medium to 35 raM resulted in increases in arachidonic acidinduced 6-keto-prostaglandin F l(< less than those obtained during Ca 2+ -free perfusion, but greater than that observed during perfusion with normal Na + (139 mM) and Ca 2+ (2.5 mM). Arachidonic acid induced 6-keto-prostaglandin F, a output was inversely correlated with tissue Ca 2+ but not Na + content. These data suggest that in the absence of perfusate Ca 2 + , the availability of exogenous arachidonic acid to cyclooxygenase is increased, possibly by reduced incorporation into tissue phospholipids. (Circulation Research 1986;59:694-703) 
Regulation by Calcium of Arachidonic Acid Metabolism in the Isolated Perfused Rabbit Heart
Margaret T. Weis and Kafait U. Malik Activation of /3-adrenergic receptors with isoproterenol fails to stimulate prostaglandin synthesis in the isolated rabbit heart perfused with Ca 2+ -free Krebs-Henseleit buffer. This lack of response could be due to reduced isoproterenol-stimulated liberation of arachidonic acid, reduced cyclooxygenase activity during Ca 2+ -free perfusion, or both. To test these hypotheses, we have examined the effect of isoproterenol and exogenous arachidonic acid on prostaglandin output in hearts perfused with Ca 2+ -containing and nominally Ca 2+ -free Krebs-Henseleit buffer. In hearts prelabelled with [ 3 H]arachidonic acid and perfused with nominally Ca 2+ -free buffer, the release of radioactivity following isoproterenol was about 90% less than when Ca 2+ was included in the perfusion buffer. When exogenous arachidonic acid was administered to hearts perfused with Ca 2+ -depleted buffer, the output of both 6-keto-prostaglandin F la and prostaglandin E 2 was about threefold greater than when Ca 2+ was present in the perfusion medium. In the absence of Ca 2+ , the dose response curve for arachidonic acid-induced 6-keto-prostaglandin F la synthesis underwent a parallel shift to the left, with no change in maximal synthesis levels, and a tenfold reduction in the ED 50 of arachidonic acid. The cyclooxygenase activities of cell-free homogenates prepared from hearts perfused with and without Ca 2+ were not different from each other and were both insensitive to added Ca 2+ . Reduction of the Na + concentration of the perfusion medium to 35 raM resulted in increases in arachidonic acidinduced 6-keto-prostaglandin F l(< less than those obtained during Ca 2+ -free perfusion, but greater than that observed during perfusion with normal Na + (139 mM) and Ca 2+ (2.5 mM). Arachidonic acid induced 6-keto-prostaglandin F, a output was inversely correlated with tissue Ca 2+ but not Na + content. These data suggest that in the absence of perfusate Ca 2 + , the availability of exogenous arachidonic acid to cyclooxygenase is increased, possibly by reduced incorporation into tissue phospholipids. (Circulation Research 1986;59:694-703) P ROSTAGLANDINS, mainly PGI 2 and PGE ? , are produced in the intact heart, isolated cardiac myocytes, 1 " 3 coronary vascular smooth muscle cells, 4 and coronary vascular endothelial cells. 5 Administration of catecholamines or sympathetic nerve stimulation promotes synthesis of prostaglandins in the heart 6 " 9 ; as little as 100 ng of isoproterenol increases the output of 6-keto-prostglandin F, o (6-keto-PGF ]Q ) by about 6 ng/min and PGE 2 by about 2 ng/min. 10 Catecholamine-stimulated cardiac prostaglandin synthesis has been linked to the activation of /3-adrenergic receptors 9 but not to increased cyclic adenosine monophosphate (cAMP) formation." Since activation of/3-adrenergic receptors is associated with increased Ca 2+ influx, 12 and Ca 2+ is required for phospholipase A 2 -and C-mediated release of arachidonic acid from tissue phospholipids," we initially investigated the relationship between Ca and iso-proterenol-stimulated prostaglandin synthesis in the isolated perfused rabbit heart.' 0 We found that isoproterenol-stimulated prostaglandin synthesis is directly proportional to and exhibits an absolute requirement for Ca 2+ in the perfusion medium. At least two nonmutally exclusive hypotheses can be offered to account for these observations. First, because the activation of phospholipases that catalyze the liberation of arachidonate from phospholipids are Ca 2+ -dependent enzymes, the reduction of available Ca 2+ would be expected to diminish their activity, resulting in decreased availability of arachidonate to cyclooxygenase. Second, Ca 2+ might serve as a cofactor of cyclooxygenase, enhancing its prostaglandin synthetic capacity. To test these hypotheses, we have 1) labelled isolated buffer-perfused rabbit hearts with [H]arachidonic acid and examined the output of radiolabelled products in response to isoproterenol; 2) examined the metabolism of arachidonic acid to prostaglandins in hearts perfused with Ca-replete and Ca-depleted buffers; and 3) investigated the effect of added Ca on the metabolism of arachidonic acid in cell-free homogenates of hearts perfused in the presence and absence of Ca.
Materials and Methods
The hearts (average wet wt. 3.66 ± 0.28 g) were removed from heparinized (1,000 U/kg) 1-2-kg male New Zealand white rabbits (Myrtle's Rabbitry, Thompson Station, Tenn.) under Na + pentobarbital anesthesia. They were mounted on a Langendorf appa-ratus and perfused with Krebs-Henseleit (KH) buffer (114.0 mM NaCl, 25.0 mM NaHCO 3 , 1.2 mM KH 2 PO 4 , 2.5 mM CaCl 2 , 1.2 mM MgSO 4 , 4.7 mM KC1, and 5.5 mM glucose). The Po 2 and Pco 2 of the perfusion buffer were maintained at 379 ± 15.3 and 40.7 ±4.04 torr, respectively, by constant bubbling with 95% O 2 /5% CO 2 . The perfusion buffer was wanned to 37°C, and the flow rate was maintained at 18 ml/min with a Harvard Peristaltic pump (Model 1203, Harvard Apparatus, South Natick, Mass.).
The coronary perfusion pressure was measured with a Statham pressure transducer (P2306; Statham Medical Instruments, Los Angeles, Calif.) attached to the aortic cannula. Myocardial tension was measured with a Grass FT.03C force-displacement transducer (Grass Instruments Co., Quincy, Mass.) connected to a stainless steel hook attached to the left ventricular apex and adjusted to provide diastolic tension of 2 g. The heart rate was measured with a tachometer triggered by the ventricular contractions. The experimental protocols were as follows:
Protocol I
The first series of experiments determined the effect of Ca 2+ -free perfusion on the isoproterenol-induced output of radioactive products from hearts prelabelled with [ 3 H]arachidonic acid. The hearts were isolated and perfused as described above. After a 20-minute stabilization period, 10 /u.Ci [ 3 H]arachidonic acid was administered by infusion (2 /xCi/min). The labelling period was followed by a 10-minute washout with KH buffer. Isoproterenol was administered as a bolus dose (100 ng) directly into the arterial circuit at 80 and 95 minutes of perfusion. Perfusate samples (18 ml) were collected for one minute periods immediately before and 20 seconds after each injection of isoproterenol, a collection schedule previously demonstrated to coincide with the maximal output of prostaglandins in response to isoproterenol.2+ l0 In time-control experiments, the Ca concentration of the perfusate was maintained at 2.5 mM throughout the experiment. In experiments testing the effect of Ca-depletion on the release of radioactivity, the perfusate was changed to nominally Ca-free KH buffer at 85 minutes, and the final dose of isoproterenol was given at 95 minutes. A portion (1 ml) of each perfusate sample was analyzed for radioactivity by liquid scintillation spectroscopy. The remainder of each sample was acidified with formic acid and extracted three times with equal volumes of ethyl acetate. The organic phases of each sample were pooled and evaporated to dryness under vacuum. The residues were redissolved in methanol and the radiolabelled products were separated by thin-layer chromatography (TLC), using iso-octane: ethyl acetate:acetic acid: water (25:55:10:50) as the solvent system. The zones corresponding to authentic standards were scraped and analyzed for radioactivity by liquid scintillation spectroscopy.
In separate experiments, the tissue distribution of [ 3 H]arachidonate was determined at 80 minutes. The labelled hearts were blotted, weighed, and extracted according to the method of Steenbergen and Jennings. 18 The total lipid extract was fractionated by TLC on silica gel F254 plates. The plates were developed to 8 cm in pentane:ethyl ether:methanol:acetic acid (110:20:10:1) and dried; they were then developed to 15 cm in petroleum ether:ethyl ether:acetic acid (168:30:2). The zones corresponding to monoglycerides, diglycerides, free fatty acids, triglycerides, and cholesterol esters were visualized in I 2 vapor, scraped, and counted by liquid scintillation spectroscopy. The phospholipids were further fractionated by thin layer chromatography (TLC) in a solvent system of chloroform : methanol: ammonium hydroxide (60:25:4). The zones corresponding to phosphatidic acid, phosphatidyl choline, phosphatidyl inositol + phosphatidyl serine, and phosphatidyl ethanolamine were visualized under I 2 vapor, scraped, and counted.
Protocol 2
The effect of nominally Ca 2+ -free perfusion on the conversion of exogenous unlabelled arachidonic acid to 6-keto-PGF ia and PGE 2 was determined according to the following protocol. The hearts were perfused as described for 35 minutes with Ca 2+ -containing KH buffer. A bolus dose of arachidonic acid (3 /xg) was administered directly into the arterial circuit at 35 and 50 minutes of perfusion. Perfusate samples (18 ml) were collected for one minute periods before and 20 seconds after each arachidonate administration. In time control experiments, the Ca 2+ concentration of the perfusate was maintained at 2.5 mM. In experiments testing the effect of nominally Ca 2+ -free perfusion on arachidonate-stimulated prostaglandin synthesis, the perfusion fluid was changed to Ca 2+ -free KH buffer at 40 minutes, 10 minutes prior to the administration of the second dose of arachidonic acid. The perfusate samples were assayed for 6-keto-PGF 1(J and PGE 2 by radioimmunoassay as described below.
The effect of nominally Ca 2+ -free perfusion on the synthesis of 6-keto-PGF, a in response to increasing doses of arachidonic acid (0.3, 1.0, 3.0, 10.0, 30.0, and 100.0 pig) was determined according to an identical protocol, except that 30-second samples (9 ml) were collected continuously for five minutes after each dose. In two of these series (3 and 30 pig of arachidonic acid), the output of PGE 2 was also measured. Since the output of both prostaglandins in response to arachidonic acid was greater in the absence than in the presence of Ca 2+ , we did not measure PGE 2 levels in subsequent series of experiments.
Protocol 3
The purpose of this series of experiments was to investigate the effect of Ca 2+ -free perfusion on the time course of 6-keto-PGF, a output following the administration of arachidonic acid. Hearts were perfused with Ca 2+ -replete KH buffer for 25 minutes, then with Ca 2+ -free KH buffer for 10 minutes (experimental) or with Ca 2+ -replete KH buffer for 35 minutes (control). Following the collection of a 3-ml perfusate sample for the determination of basal 6-keto-PGF la levels, a bolus dose of arachidonic acid (3 fx,g) was administered directly into the arterial circuit; samples (1.5 ml) were collected at 5-second intervals for five minutes and analyzed for 6-keto-PGF, Q as described below.
Protocol 4
The effect of Ca 2+ -free perfusion on the conversion of [
14 C]arachidonic acid to prostaglandins was examined according to a protocol similar to that described for unlabelled arachidonic acid (Protocol 2). The hearts were perfused for 25 minutes with Ca 2+ -replete KH buffer, followed by 10-minute perfusion with Ca 2+ -depleted KH buffer, or for 35 minutes with KH buffer containing Ca 2+ . Both series of experiments were also repeated with KH buffer containing indomethacin (2.7 fiM). At 35 minutes perfusion, a bolus dose of [
14 C]arachidonic acid (0.5 fj.Ci) was administered into the arterial circuit. The perfusate was collected for five minutes (90 ml), acidified, and extracted with ethyl acetate. The radiolabelled products in the extracts were separated by TLC as described in Protocol 1.
Protocol 5
Since removal of Ca 2+ from the perfusion medium is known to cause loss of tissue Ca 2+ in the rabbit and rat heart, 19 
"
22 and since it has been reported that this loss is minimized if the Na + concentration is reduced to 35 mM during Ca 2+ -free perfusion, 20 we examined the effect of low Na + , Ca 2+ -free perfusion on arachidonic acid stimulated 6-keto-PGF, a output. Hearts were perfused as described for 25 minutes with Ca 2+ -replete KH buffer, followed by 10 minutes with one of the following: 1) Ca 2+ -depleted KH buffer (139 mM Na\ 0 Ca 2+ ); 2) low Na + KH buffer (35 mM Na + , 2.5 mM Ca 2+ ); 3) low Na + , Ca 2+ -depleted KH buffer (35 mM Na + , 0 Ca 2+ ); or 4) normal KH buffer (139 mM Na + , 2.5 mM Ca 2+ ). Where necessary, the buffer was adjusted to 280 mOsm/1 with sucrose. At 35 minutes, a perfusate sample was collected for the determination of basal 6-keto-PGF, a output and a single bolus dose of arachidonic acid (3 /xg) was administered into the arterial circuit. Perfusate samples (9 ml) were collected at 30-second intervals for five minutes and analyzed for 6-keto-PGF la content by radioimmunoassay as described below. After collection of the final sample, the hearts were flushed with 100 ml ice-cold sucrose-HEPES (SH) buffer (350 mM sucrose, 10 mM HEPES, pH adjusted to 7.4 with 1 M Tris base) to clear the vascular spaces of KH buffer. The hearts were blotted, dried to a constant weight at 100°C, and digested for 48-72 hours in 5 ml of concentrated nitric acid. The Na + concentration of the digest was determined by flame photometry and the Ca 2+ concentration by atomic absorption spectrometry.
Protocol 6
In this series of experiments, we indirectly estimated the effect of Ca 2+ -free perfusion on cyclooxygenase by measuring the conversion of arachidonic acid to 6-keto-PGF, Q by cell-free homogenates of hearts perfused in the presence or absence of Ca 2+ . Hearts were perfused for 25 minutes with Ca 2+ -containing KH buffer followed by 10-minute perfusion with Ca 2+ -free KH buffer. Control hearts were perfused for 35 minutes with Ca 2+ -containing KH buffer. At the end of the perfusion, the hearts were flushed with 100 ml ice-cold SH buffer, blotted, weighed, and minced. The tissue fragments were suspended in 3 volumes of ice-cold SH buffer and homogenized twice for 30 seconds with a Polytron homogenizer (Type 10 20 3500, Brinkman Instruments Co., Houston, Tex.) at maximum energy setting. The homogenizer tube and probe were rinsed with 2 volumes of SH buffer. The homogenate and rinse were pooled and centrifuged at 10,000g for 30 minutes. The pellet was discarded and the supernate recentrifuged at 100,000g for 65 minutes. The resulting pellet was resuspended in SH buffer to a final protein concentration of 1 mg/ml, as determined by the method of Bradford 23 and stored at -70°C until used. Cyclooxygenase activity was measured by adding 100 jug homogenate protein to tubes containing arachidonic acid (final concentration 1-20 /xM) and Ca (final concentration 0-1 mM), prepared in SH buffer with the final volume adjusted to 400 fi\ with SH buffer. The reaction was allowed to proceed for 10 minutes at 37° C in an atmosphere of 100% O 2 . The reaction was terminated by the addition of indomethacin to a final concentration of 100 JLAM, followed by dilution to 4.5 ml with 1 mM HC1. Prostaglandins were extracted immediately on C, 8 SepPaks (Waters Associates, Milford MA) as described previously; the dried residue was redissolved in KH buffer, and 6-keto-PFG, n was measured by radioimmunoassay as described below. Tissue blanks consisted of homogenate protein added to assay tubes containing indomethacin; these were acidified and extracted immediately without incubation.
Radioimmunoassay of Prostaglandins
PGE 2 and 6-keto-PGF, a concentrations in the perfusate samples were determined by radioimmunioassay. The sample (60-100 /AI) was mixed with 3,000-5,000 cpm of tracer plus the appropriate concentration of antibody, obtained from Dr. Charles Leffler, Department of Physiology, University of Tennessee, Memphis. The tracer and antibody were prepared in a buffer consisting of (g/1) NaN 3 , 1.0; NaCl, 9.0 KH 2 PO 4 , 6.8; K 2 HPO 4 , 26.1, and gelatin, 2.0. Standards (3-1,600 pg) were prepared in KH buffer. After vortexing, the tubes were incubated overnight at 4°C. Bound and free tracers were separated by adding 1 ml of dextran-coated charcoal to each tube. After centrifugation, the supernate was decanted into 5 ml of counting cocktail and the radioactivity was determined by liquid scintillation spectroscopy. Cross-reactivity of the 6-keto-PGF, a antibody was less than 0.1% with thromboxane B 2 (TXB 2 ), 13,14-dihydro-15-keto-PGE 2 and PGI 2 , and less than 0.5% with PGE 2 and PGF 2a . The crossreactivity of the PGE 2 antibody was less than 0.1% with 6-keto-PGF, a , PGF 2a , PGD 2 , TXB 2 , 13,14-dihydro-15-keto-PGE 2 , and arachidonic acid.
Drugs
Arachidonic acid was purchased from NuChek Preparations, Inc., Elysian, Minn. It was prepared as a 20-mg/ml stock solution in ethanol and stored at -20°C in a light-proof container. Immediately before use it was diluted 1:1 in 10 mM Tris buffer, followed by further dilution in KH buffer (for administration to perfused hearts) or SH buffer (for use in cyclooxygenase assays). Indomethacin and isoproterenol were purchased from Sigma Chemical Co., St. Louis, Mo. Indomethacin was prepared fresh daily in 10 mM Tris buffer; isoproterenol was prepared fresh daily in KH buffer. Unlabelled prostaglandins were the generous gift of The Upjohn Company, Kalamazoo, Mich. They were prepared to 10 /Ag/ml stock solutions in ethanol (PGE 2 ) or acetonitrile (6-keto-PGF lQ ) and stored at -20°C. 
Analysis of Data
The results are expressed as means ± SEM. The data were analyzed by Student's t test for paired or unpaired observations; by one-way, two-way, or splitplot two-way analysis of variance; or by analysis of covariance. The null hypothesis was rejected at p< 0.05. Dose-response curves to arachidonic acid were linearized according to the method of Hill, 25 so that slopes and Ed 50 's could be computed and compared.
Results
The heart rate, developed tension, and perfusion pressure measured at 20 minutes of perfusion with normal KH buffer did not differ within or between experimental groups. The average values were 1) heart rate, 166 ±3 beats/min; 2) perfusion pressure, 41 ± 2.2 mm Hg; and 3) developed tension, 17.2 ± 0.7 g. When Ca 2+ was removed from the buffer, the basal perfusion pressure fell, 22 ± 3 mmHg, and returned to baseline level within five minutes; developed tension fell to 0, and the heart stopped beating. The administration of isoproterenol (100 ng) increased the heart rate by 121 ±4 beats/min and developed tension by 8.7 ±1.9 g, and decreased perfusion pressure by 11 ± 4 mm Hg. These responses were lost when the drug was administered during Ca 2+ -free perfusion. The administration of arachidonic acid produced no consistent change in any mechanical parameter except at 100 /Ag, which decreased the perfusion pressure by an average of 12.7 ± 5.7 mm Hg during perfusion with Ca 2+ -containing buffer. In the absence of Ca 2+ , arachidonic acid did not alter perfusion pressure. During perfusion with KH buffer containing 35 mM Na + , 2.5 mM Ca 2+ , the systolic tension rose 7.3 ± 1.3 g; the heart beat only sporadically, although the magnitude of the developed tension was not changed from that observed at 20 minutes. The decrease in pO 2 during passage of perfusion fluid through the heart was 94±16.2 torr. The pO 2 of the perfusion buffer and O 2 extraction were not altered in the absence of Ca 2+ . The mean lactate level in the perfusate during the duration of the experiments was 68.4 ± 8.4 /xM, indicating that the preparations remained normoxic. Except where specifically stated, basal prostaglandin synthesis remained constant.
Effect of Isoproterenol on the Output of Radioactive Products From Hearts Prelabelled With [ 3 H]Arachidonic Acid
In time-control experiments, bolus doses of isoproterenol administered at 80 and 95 minutes perfusion increased the outflow of tritium by 3,864 ± 1,690 and 3,918 ± 131 dpm, respectively (Figure 1) . In experimental hearts, bolus doses of isoproterenol at 80 minutes of perfusion increased the outflow of radioactivity by 4,752 ±2,412 dpm. Of this radioactivity, 17 ±2% corresponded to authentic 6-keto-PGF, a , and 64 ± 3% corresponded to authentic arachidonic acid. After 10 minutes of Ca 2+ -free perfusion, isoproterenol released only 372 ±114 dpm of radioactivity, of which 14.8 ± 8% corresponded to authentic 6-keto-PGF, a and 66 ± 15% corresponded to authentic arachidonic acid. These values were not significantly different from those found in the presence of Ca 2+ . The basal outflow of radioactivity fell with time, but was not altered by Ca 2+ -free perfusion. The total radioactivity remaining in the heart at the time of the first dose of isoproterenol was 54,284 dpm/mg lipid. This radioactivity was distributed as follows: 82%, total phospholipids; 47%, phosphatidyl choline; 17%, phosphatidyl ethanolamine; 17%, phosphatidyl serine + phosphatidyl inositol; 2%, phosphatidic acid; 2%, monoglycerides; 5%, diglycerides; 6%, triglycerides; 3%, free fatty acids; and 2%, cholesterol esters. This distribution of radioactivity is in agreement with that observed by Hsueh et al. 26 
Effect of Calcium-Free Perfusion on the Conversion of Unlabelled Arachidonic Acid to Prostaglandins
The conversion of unlabelled arachidonic acid to 6-keto-PGF, a and PGE 2 was measured in the presence Figure 2 . In time-control experiments, the administration of 3 /Ag bolus doses of arachidonic acid at 35 and 50 minutes of perfusion resulted in approximately equal increases in both 6-keto-PGF, a and PGE 2 output. However, when arachidonate was administered following 10 minutes of Ca 2+ -free perfusion, the synthesis of both prostaglandins was nearly tripled. Following a 30-ju.g bolus dose of arachidonic acid, the output of 6-keto-PGF, a was 56.9 ±11.3 ng/min in the presence of Ca 2+ and 150 ± 13.8 hg/min in its absence. The output of PGE 2 following this dose of arachidonic acid was 3.23 ±0.16 ng/min and 21.1 ± 5.74 ng/min, respectively.
Metabolism of [ I4 C]Arachidonic Acid in the Absence of Calcium
Thin-layer chromatograms of the extractable radioactivity in the perfusate following the administration of [ 14 C] arachidonic acid are shown in Figure 3 . In both the presence and absence of Ca 2+ the radiolabelled products comigrated with authentic 6-keto-PGF, 0 , PGE 2 , PGF 2Q , and arachidonic acid. The areas under the peaks of radioactivity corresponding to authentic prostaglandins were 3.02 (6-keto-PGF, J, 2.52 (PGE 2 ), and 1.48 (PGF 2a ) times greater from hearts perfused without Ca 2+ than from hearts perfused with Ca 2+ . In the presence of indomethacin, only peaks corresponding to authentic arachidonic acid appear in both the presence and absence of Ca 2+ .
Effect of Calcium-Free Perfusion on the Time Course of 6-Keto-PGF la Output in Response to Arachidonic Acid
In the absence of Ca 2+ , the increased conversion of arachidonic acid to prostaglandins could be due to 1) i more rapid delivery of substrate to cyclooxygenase; 2) increased total delivery of substrate to cyclooxygenase; or 3) more rapid efflux of prostaglandins from the tissue following synthesis. To investigate these possibilities, single bolus doses of arachidonic acid were administered at 35 minutes of perfusion and perfusate samples (1.5 ml) were collected every five seconds for five minutes; these were analyzed for 6-keto-PGF la .
The time to peak output of 6-keto-PGF, a shown in Figure 4 was 42 ± 3 seconds in the presence and 
Conversion of Unlabelled Arachidonic Acid to Prosta gland ins in Hearts Perfused With Low Sodium, Calcium-Free Buffer
In hearts perfused with 35 mM Na + , Ca 2+ -free KH buffer, the arachidonic-acid-induced output of 6-keto-PGF, a was significantly reduced compared to that in hearts perfused with 139 mM Na + , Ca 2+ -free KH buffer, but was significantly greater than in hearts perfused with KH buffer containing 139 mM Na + , 2.5 mM Ca 2+ ( Figure 6 ). The Ca 2+ content of the hearts was plotted vs. the 6-keto-PGF, a output ( Figure 7) . As the Ca 2+ content rose, the conversion of arachidonate to 6-keto-PGF, n fell (r = -0.603;/><0.05). There was no significant relation between 6-keto-PGF la synthesis and Na + content (r = -0.295; p>0.10). The basal output of 6-keto-PGF, a was not altered during perfusion with low Na + , Ca 2+ -free or normal Na + , Ca 2+ -free KH buffer. During perfusion with 35 mM Na + , 2.5 mM Ca 2+ buffer, basal 6-keto-PGF, Q output was significantly increased compared to all other groups (4.53 ±0.53 ng/min vs. 44.6 ± 9.6 ng/min; p< 0.001; Figure 6 ). 
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6-Keto-PGF la Synthesis in Cell-Free Homogenates of Hearts Perfused With and Without Ca
2+
Homogenates were prepared from hearts perfused in the presence or absence of Ca 2+ as described in "Materials and Methods." Cyclooxygenase activity as measured by the synthesis of 6-keto-PGF lQ was linear with protein concentration and time for 15 minutes. The K m and V max of the cardiac cyclooxygenase were estimated by incubating homogenates in the presence of increasing concentrations of arachidonic acid with or without added Ca 2+ . The results of these experiments are shown in Table 2 . These values were not significantly changed when CaCl 2 was added to the assay mixture ( Table 2) .
Discussion
The present study indicates that Ca 2+ influences cardiac prostaglandin synthesis by regulating arachidonic acid availability to cyclooxygenase. This conclusion is based on our observation that, in the isolated rabbit heart, the lack of extracellular Ca 2+ inhibits j3-adrenergic receptor-stimulated release of arachidonic acid but increases the conversion of this fatty acid to prostaglandins without altering cyclooxygenase activity.
Cardiac prostaglandin synthesis in response to /3-adrenergic receptor activation is dependent upon Ca 2+ , 27 In the absence of extracellular Ca 2+ , isoproterenol (a /3-adrenergic receptor agonist) fails to increase prostaglandin synthesis; as the Ca 2+ concentration is increased, prostaglandin synthesis in response to isoproterenol also increases. In the present study 1) isoproterenol increased the outflow of tritium from hearts prelabelled with [ 3 H]arachidonic acid; 2) this material had the chromatographic mobility of arachidonic acid (66%), 6-keto-PGF la , and PGE 2 ; and 3) the increase in isoproterenol-induced release of tritium was abolished in the absence of extracellular Ca 2+ . These observations, taken together with the finding that 1) activation of /8-adrenergic receptors is associated with an increased influx of Ca 2+ ; 12 and 2) Ca 2+ is required for the activation of the phospholipases that release arachidonic acid from tissue lipids,' 3 " 17 suggest that /3-adrenergic-receptor-stimulated influx of Ca 2+ promotes prostaglandin synthesis in the heart by activating lipase(s) that release arachidonic acid from tissue lipids.
Although, in the present study, reduced release of arachidonic acid from tissue lipids could account for the Ca 2+ dependence of isoproterenol-stimulated prostaglandin synthesis, it is possible that decreased cyclooxygenase activity might be a contributing factor. However, this appears to be unlikely since 6-keto-PGF, a and PGE 2 output following the administration of arachidonic acid were markedly increased. Enhanced production of prostaglandins from arachidonic acid during Ca 2+ -free perfusion could be due to alterations in 1) the profile of arachidonic acid metabolites; 2) the dynamics of delivery of arachidonate to cyclooxygenase; or 3) the intrinsic activity of cyclooxygenase (K m or V max ). The first possibility appears to be unlikely, since the administration of [ l4 C]arachidonic acid to hearts perfused with or without Ca 2+ generated radiolabelled products that exhibited chromatographic mobilities similar to each other and to authentic prostaglandins. The profiles were similar; however, the amount of radiolabelled products, as indicated by the peak heights, was much higher in hearts perfused in the absence of Ca 2+ . Since pretreatment of hearts with indomethacin abolished the generation of radiolabelled products from f'
4 C]arachidonate in both the presence and absence of Ca 2+ , they are most likely derived through the cyclooxygenase pathway.
The increased production of prostaglandins from arachidonic acid during Ca 2+ -free perfusion could result from increased delivery of arachidonic acid to cyclooxygenase. Since during Ca 2+ -free perfusion there is a separation of the myocytes at the intercalated discs 28 and separation of the glycocalix from the sarco- The K m and V mal of cyclooxygenase in the presence of increasing concentrations of Ca 2+ were estimated by measuring the production of 6-keto-PGF| n for both experimental (perfused with 2.5 mM Ca 2+ KH buffer) and control (perfused with nominally Ca 2+ -free KH buffer) hearts. The values were obtained from double reciprocal plots. Each value represents the mean ± SEM of 3 preparations. The data were analyzed by split-plot two-way analysis of variance, which showed no significant differences between control and experimental hearts. lemma, 2930 the availability of exogenous arachidonic acid to cyclooxygenase could be increased by simple removal of one of these permeability barriers. If so, then it would be expected that the time required to reach peak synthesis would be decreased during Ca 2+ -free perfusion; in addition the rate at which output declines (a function of the ability of product to move from the intracellular site of synthesis to the extracellular and vascular spaces) would be expected to be faster during Ca 2+ -free perfusion. In our experiments, the time required to reach peak synthesis and the rate at which prostaglandin output declined were unchanged during Ca 2+ -free perfusion. However the peak height and total prostaglandin output over a five-minute period were significantly greater in the absence of perfusate Ca 2+ . These results suggest that the amount of arachidonic acid available to cyclooxygenase is increased, but that the tissue permeability of the fatty acid is unchanged. Additionally, the proportion of radioactivity comigrating with authentic arachidonic acid following stimulation by isoproterenol in hearts prelabelled with [ 3 H]arachidonic acid was the same in the presence and absence of Ca 2+ , indicating that the reuptake of the fatty acid is not altered. Supporting this view, it has been reported that the uptake of labelled arachidonic acid in the rabbit heart 27 and palmitate in cultured cardiac myocytes 31 is not changed in the absence of Ca 2+ .
If increased prostaglandin synthesis observed in the absence of Ca 2+ were the result of increased availability of substrate to cyclooxygenase, then it should be possible to overcome the difference by giving a sufficiently high dose of arachidonic acid. Our finding that the dose-response curves for arachidonic-acid-induced 6-keto-PGF, a output underwent a parallel shift to the left in the absence of Ca 2+ are consistent with the notion that either more arachidonic acid is available to cyclooxygenase in the absence of Ca 2+ , or that Ca 2+ behaves as a competitive inhibitor of cyclooxygenase. The latter seems to be unlikely, since the conversion of arachidonic acid to prostaglandins by cell-free homogenates of hearts perfused in the presence and absence of Ca 2+ was not different. Addition of Ca 2+ to these cell-free homogenates failed to alter the production of prostaglandins from arachidonic acid; this observation is consistent with that of Nugteren et al, 32 who observed no effect of Ca 2+ on cyclooxygenase activity isolated from sheep seminal vesicles.
The mechanism by which lack of extracellular Ca 20 Therefore, it is possible that enhanced availability of arachidonic acid to cyclooxygenase might be due to increased cellular Na + . In our study in rabbit hearts perfused with nominally Ca 2+ -free, normal Na + (139 mM) buffer, the conversion of arachidonic acid to prostaglandins was markedly increased. The tissue content of Ca 2+ was reduced by 31%, a value consistent with that reported by other investigators during Ca 2+ -free perfusion.' 920 - 22 However, in our experiments the tissue content of Na + did not increase but was reduced. This is in contrast to the rat heart in which the tissue content of Na + has been reported to increase 21 or remain unchanged 20 was reduced in the rabbit heart, the conversion of arachidonic acid to 6-keto-PGF, a was less than that observed during normal Na + , Ca 2+ -free perfusion, but significantly greater than that obtained during normal Na + , normal Ca 2+ perfusion.
The tissue content of Ca 2+ but not Na + was significantly correlated with the conversion of arachidonic acid to 6-keto-PGF, Q ; viz, the higher the Ca 2+ the lower the production of 6-keto-PGF, a in response to arachidonic acid. These observations are consistent with our contention that the availability of arachidonic acid to cyclooxygenase for prostaglandin production is regulated by Ca 2+ . Since we measured total cardiac content of Ca 2+ andNa + and the conversion of arachidonic acid to 6-keto-PGF| tt occurs predominantly in the coronary vasculature in the perfused heart, 33 we cannot make any accurate inferences about the cardiac structures and/or the cellular stores of Ca 2+ that participate in governing the availability of arachidonic acid to cyclooxygenase. For similar reasons, we cannot exclude the contribution of other cations in influencing the delivery to and/or metabolism of arachidonic acid to cyclooxygenase. Moreover, the effect of Ca 2+ on the availability of arachidonic acid to cyclooxygenase might be selective in the heart, because Ca 2+ -free perfusion does not alter the conversion of arachidonic acid to prostanoids in the rabbit kidney (Weis and Malik, unpublished observations).
Although Ca 2+ -free perfusion inhibited /3-adrenergic receptor-activated and enhanced arachidonic acidinduced production of prostaglandins, it failed to alter the basal output of 6-keto-PGF, Q or PGE 2 . Moreover, during alteration in extracellular Ca 2+ and Na + there was no relationship between the basal output of 6-keto-PGF la and the tissue content of Ca 2+ or Na + . These observations suggest that the lipase involved in the hormonally stimulated release of arachidonic acid is distinct, and/or the lipid pool that contributes to the release of this fatty acid is different from that operating under basal conditions. Further, the pathways for the disposition of endogenous and exogenous arachidonic acid may be different.
This study demonstrates that in the isolated rabbit heart activation of /3-adrenergic receptors promotes prostaglandin synthesis by stimulating liberation of arachidonic acid from tissue lipids, a process that appears to be regulated by Ca 2+ . More importantly, this study provides evidence that extracellular Ca 2+ also regulates prostaglandin production by enhancing the delivery of free arachidonic acid to cyclooxygenase. The precise mechanism by which Ca 2+ regulates the availability of arachidonate to cyclooxygenase is currently under investigation. Our preliminary results indicate that in the absence of Ca 2+ , less arachidonate is incorporated into tissue phospholipids. 27 Therefore, it is possible that Ca 2+ might regulate cardiac prostaglandin synthesis not only by promoting deacylation but also by influencing esterification of arachidonic acid into tissue lipids in the heart.
If Ca 2+ -free perfusion is, as has been proposed, a model for myocardial ischemia, 34 then the findings outlined here might help to explain the accumulation of free fatty acids, especially arachidonate, that has been observed in the ischemic heart. 35 - 36 In particular, it has been reported that during ischemia the arachidonic acid content of phosphatidyl choline and phosphatidyl ethanolamine is diminished and that the oleic acid content of these same phospholipids is increased. 36 These observations are in agreement with our hypothesis that during Ca 2 + -free perfusion the incorporation of arachidonic acid into tissue phospholipids is inhibited, 27 resulting in increased availability of arachidonic acid to the enzyme cyclooxygenase.
